Back to search results

Targeted Palliative Care for Metastatic Breast Cancer

This study is for people with metastatic breast cancer (cancer that has spread to other parts of the body). It tests a special palliative care program called "TARGET-PC." Palliative care helps manage symptoms, improve communication with doctors, and support you and your family. The study wants to see if TARGET-PC, which focuses on your goals and values, works better than standard care to help you talk about your healthcare wishes. You might be able to join if you are at least 18 years old, have metastatic breast cancer, and meet other health requirements. The main goal is to see if your end-of-life care preferences are documented more often.

Study design
This study will include 400 patients with metastatic breast cancer. Participants will be randomly assigned to either receive the TARGET-PC program or enhanced usual care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from the date of randomization until death or last follow-up, for up to 60 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06795529

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

Recruiting
NAAges 18+InterventionalSupportive care
Massachusetts General Hospital
~400 participants
Updated 2025-11-18 on ClinicalTrials.gov
What's tested:Palliative Care Intervention, "TARGET-PC"Enhanced Usual Care

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Documentation of End-of-Life Care Preferences
Measured over From date of randomization until date of death or last follow up assessed up to 60 months

Conditions

Metastatic Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

3 sites across 3 states
Massachusetts1
North Carolina1
Pennsylvania1

Who to contact

Jennifer Temel, MD
[email protected]
617-724-4000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age ≥18 years
diagnosed with metastatic breast cancer
within 8 weeks of the oncology visit at which they were identified as having an eligible Epic EOL Care Index (≥ 15)
functioning independently per an Eastern Cooperative Oncology Group performance status ≤2
receiving their cancer care at one of the participating institutions
able to complete questionnaires in English or Spanish
age ≥18 years
identified by the patient as a family member or friend who is primarily involved in their care
able to complete questionnaires in English or Spanish

Exclusion

received outpatient palliative care visit within the last six months
enrolled in hospice services
diagnosed with a comorbid condition that impairs their ability to understand study procedures and/or consent for the trial as per the report of the oncology clinician(s)

What this trial measures

  • Documentation of End-of-Life Care PreferencesFrom date of randomization until date of death or last follow up assessed up to 60 months

    To compare proportions of patients with clinician-documented end-of-life care preferences in the electronic health record by last follow-up time point or date of death between study groups.